Declining Stock and Solid Fundamentals: Is The Market Wrong About Afya Limited (NASDAQ:AFYA)?
Afya Initiated at Sell by Goldman Sachs
Afya Price Target Announced at $16.00/Share by Goldman Sachs
Express News | Goldman Sachs Initiates Coverage On Afya With Sell Rating, Announces Price Target of $16
Afya Analyst Ratings
Zscaler, TransMedics Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Here's Why We Think Afya (NASDAQ:AFYA) Is Well Worth Watching
Returns On Capital Are Showing Encouraging Signs At Afya (NASDAQ:AFYA)
Morgan Stanley Maintains Afya Ltd(AFYA.US) With Hold Rating, Raises Target Price to $19
BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating, Maintains Target Price $25
Afya Limited Reports Strong Q3 2024 Financial Growth
Afya (AFYA) Q3 Earnings Miss Estimates
Afya Backs 2024 Rev BRL3.225B-BRL3.325B >AFYA
Afya 3Q Adj EPS BRL1.79 >AFYA
Afya 3Q EPS BRL1.33 >AFYA
Afya Limited Third Quarter and Nine Months 2024 Financial Results
Express News | Afya Ltd - Reaffirms Guidance FY2024
Express News | Afya Ltd - Qtrly Net Rev R$841.2 Mln
Express News | Afya Limited Q3 2024 Adj. EPS $0.32, Revenue $151.639M
Afya Ltd | 6-K: Report of foreign private issuer (related to financial reporting)